These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 16105892)
1. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I. Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892 [TBL] [Abstract][Full Text] [Related]
2. Unexpected dose to the daughter of a patient treated with iodine-131 for hyperthyroidism. Molyvda-Athanasopoulou E; Karaveli M; Chatzigiannaki A; Gotzamani-Psarrakou A Hell J Nucl Med; 2007; 10(3):175-6. PubMed ID: 18084660 [TBL] [Abstract][Full Text] [Related]
3. [Problems with radiation protection for adjuvant radiotherapy of thyroid cancer]. Siekierzyński M Wiad Lek; 2001; 54 Suppl 1():307-11. PubMed ID: 12182040 [TBL] [Abstract][Full Text] [Related]
4. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe? de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231 [TBL] [Abstract][Full Text] [Related]
5. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy. Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067 [TBL] [Abstract][Full Text] [Related]
6. Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposure. Gabriel S; Farman-Ara B; Bourrelly M; Carpentier O; Sebag F; Palazzo FF; De Micco C; Mancini J; Henry JF; Mundler O; Taïeb D Nucl Med Commun; 2011 Sep; 32(9):829-33. PubMed ID: 21633315 [TBL] [Abstract][Full Text] [Related]
7. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845 [TBL] [Abstract][Full Text] [Related]
8. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy. Parthasarathy KL; Crawford ES J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749 [TBL] [Abstract][Full Text] [Related]
9. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism. Stabin MG; Watson EE; Marcus CS; Salk RD J Nucl Med; 1991 May; 32(5):808-13. PubMed ID: 2022987 [TBL] [Abstract][Full Text] [Related]
10. Measurement of radiation exposure in relatives of thyroid cancer patients treated with (131)I. Ramírez-Garzón YT; Ávila O; Medina LA; Gamboa-deBuen I; Rodríguez-Laguna A; Buenfil AE; Ruíz-Trejo C; Estrada E; Brandan ME Health Phys; 2014 Nov; 107(5):410-6. PubMed ID: 25271931 [TBL] [Abstract][Full Text] [Related]
11. Hospital discharge of patients with thyroid carcinoma treated with 131I. Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704 [TBL] [Abstract][Full Text] [Related]
12. [Measurement of incorporation in family members of radioiodine therapy patients after therapy of benign thyroid diseases]. Lassmann M; Hänscheid H; Schelper LF; Körber C; Reiners C Nuklearmedizin; 1998 May; 37(3):120-3. PubMed ID: 9604233 [TBL] [Abstract][Full Text] [Related]
13. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK Eur J Nucl Med; 1999 Jul; 26(7):686-92. PubMed ID: 10398815 [TBL] [Abstract][Full Text] [Related]
14. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy. Kusakabe K; Yokoyama K; Ito K; Shibuya H; Kinuya S; Ito M; Higashi T; Togawa T; Koizumi K; Yoshimura M; Uchiyama M; Okamoto T; Kanaya S; Kanaya K; Yoneyama T; Ikebuchi H; Yanagida S; Shibata K; Segawa K; Yamamoto A Ann Nucl Med; 2012 May; 26(4):370-8. PubMed ID: 22450825 [TBL] [Abstract][Full Text] [Related]
15. [Environmental radiation exposure of a thyroid cancer patient resulting from adjuvant iodine radiotherapy]. Chaś J; Kowalczyk A; Siekierzyński M; Dziuk E; Janiak MK Wiad Lek; 2001; 54 Suppl 1():312-20. PubMed ID: 12182042 [TBL] [Abstract][Full Text] [Related]
16. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review. Al-Shakhrah IA Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384 [TBL] [Abstract][Full Text] [Related]
17. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. Liu B; Kuang A; Huang R; Zhao Z; Zeng Y; Wang J; Tian R J Nucl Med; 2010 Apr; 51(4):618-23. PubMed ID: 20237029 [TBL] [Abstract][Full Text] [Related]
18. Labelled amino acids in plasma of patients with thyrotoxicosis and thyroid cancer after radioiodine treatment. Bednár J; Nĕmec J; Soutorová M; Neradilová M; Pohunková D; Zamrazil V; Vána S; Havelka J; Röhling S Endocrinol Exp; 1979 Mar; 13(1):53-63. PubMed ID: 316382 [TBL] [Abstract][Full Text] [Related]
19. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements. Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877 [TBL] [Abstract][Full Text] [Related]